×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PLSE – pulse biosciences, inc (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PLSE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/18
03:40 am
plse
Truffle Capital Unveils the First Edition of the Truffle MedTech 10 [Yahoo! Finance]
Low
Report
Truffle Capital Unveils the First Edition of the Truffle MedTech 10 [Yahoo! Finance]
3/17
07:36 am
plse
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data [Yahoo! Finance]
Medium
Report
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data [Yahoo! Finance]
3/17
07:00 am
plse
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
Low
Report
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
3/16
12:29 pm
plse
Is Pulse Biosciences' (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? [Yahoo! Finance]
Low
Report
Is Pulse Biosciences' (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? [Yahoo! Finance]
3/16
11:54 am
plse
A Look At Pulse Biosciences (PLSE) Valuation As Thyroid Cancer Feasibility Study Begins [Yahoo! Finance]
Low
Report
A Look At Pulse Biosciences (PLSE) Valuation As Thyroid Cancer Feasibility Study Begins [Yahoo! Finance]
3/12
07:23 am
plse
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology [Yahoo! Finance]
Medium
Report
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology [Yahoo! Finance]
3/12
07:00 am
plse
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
Medium
Report
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
3/9
07:03 am
plse
Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation [Yahoo! Finance]
Low
Report
Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
2/20
10:02 am
Reiterates
Outperform
Outperform
Oppenheimer Holdings, Inc.
Medium
Report
-9.7%
Date
Time
Symbol
Headline
Impact
3/17
08:59 am
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Mar 17
Low
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Mar 17
3/12
09:21 am
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Mar 12
Medium
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Mar 12
3/9
09:32 am
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Mar 06
Low
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Mar 06
3/3
04:39 pm
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Mar 03
Low
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Mar 03
3/2
09:22 am
plse
Form 8-K/A PULSE BIOSCIENCES, INC. For: Feb 27
Medium
Report
Form 8-K/A PULSE BIOSCIENCES, INC. For: Feb 27
3/2
06:09 am
plse
Form EFFECT PULSE BIOSCIENCES, INC.
Low
Report
Form EFFECT PULSE BIOSCIENCES, INC.
2/27
05:26 pm
plse
Form 8-K PULSE BIOSCIENCES, INC. For: Feb 27
Low
Report
Form 8-K PULSE BIOSCIENCES, INC. For: Feb 27
2/23
08:55 pm
plse
Form 4 PULSE BIOSCIENCES, INC. For: Feb 18 Filed by: Danahy Kevin Patrick
Medium
Report
Form 4 PULSE BIOSCIENCES, INC. For: Feb 18 Filed by: Danahy Kevin Patrick
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Pulse Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results
33.7%
4/6 Form S-3 Pulse Biosciences, Inc. 11.5%
4/29 Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020 7.8%
9/10 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.5%
3/31 Form 10-K/A Pulse Biosciences, Inc. For: Dec 31 6.7%
4/14 Form S-3/A Pulse Biosciences, Inc. 5.9%
2/11 Pulse Biosciences Inc (NASDAQ: PLSE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
4/21 Form S-3/A Pulse Biosciences, Inc. 5.0%
12/19 Form 8-K Pulse Biosciences, Inc. For: Dec 19 4.8%
9/4 Pulse Biosciences Grants Equity Incentive Awards to New Employees 4.2%
4/6 Form S-3 Pulse Biosciences, Inc. 11.5%
4/29 Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020 7.8%
9/10 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.5%
3/31 Form 10-K/A Pulse Biosciences, Inc. For: Dec 31 6.7%
4/14 Form S-3/A Pulse Biosciences, Inc. 5.9%
2/11 Pulse Biosciences Inc (NASDAQ: PLSE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
4/21 Form S-3/A Pulse Biosciences, Inc. 5.0%
12/19 Form 8-K Pulse Biosciences, Inc. For: Dec 19 4.8%
9/4 Pulse Biosciences Grants Equity Incentive Awards to New Employees 4.2%
TOP News Decliners
2/13
Pulse Biosciences Provides Update on FDA 510(k) Submission for the CellFX System in Dermatology
-29.8%
5/1 Form S-3/A Pulse Biosciences, Inc. -23.4%
3/17 Pulse Biosciences Grants Equity Incentive Awards to New Employees -10.3%
4/14 Form DEF 14A Pulse Biosciences, Inc. For: Apr 14 -7.8%
8/8 Form 10-Q Pulse Biosciences, Inc. For: Jun 30 -6.9%
12/18 Pulse Biosciences Updates on Regulatory Progress -5.4%
11/19 Form 3 Pulse Biosciences, Inc. For: Nov 18 Filed by: GARDINER SANDRA A. -4.9%
3/12 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -4.4%
5/17 Form 8-K Pulse Biosciences, Inc. For: May 16 -4.4%
9/26 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%
5/1 Form S-3/A Pulse Biosciences, Inc. -23.4%
3/17 Pulse Biosciences Grants Equity Incentive Awards to New Employees -10.3%
4/14 Form DEF 14A Pulse Biosciences, Inc. For: Apr 14 -7.8%
8/8 Form 10-Q Pulse Biosciences, Inc. For: Jun 30 -6.9%
12/18 Pulse Biosciences Updates on Regulatory Progress -5.4%
11/19 Form 3 Pulse Biosciences, Inc. For: Nov 18 Filed by: GARDINER SANDRA A. -4.9%
3/12 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -4.4%
5/17 Form 8-K Pulse Biosciences, Inc. For: May 16 -4.4%
9/26 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: